Polaryx Therapeutics, Inc.
PLYX
$2.08
$0.062.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.54M | 3.08M | 5.14M | 5.75M | 3.30M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 270.00K | 389.00K | -- | 82.00K | 201.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 33.00K | 27.00K | 156.00K | 38.00K |
| Total Current Assets | 11.81M | 3.50M | 5.17M | 5.98M | 3.54M |
|
|
|||||
| Total Current Assets | 11.81M | 3.50M | 5.17M | 5.98M | 3.54M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.81M | 3.50M | 5.17M | 5.98M | 3.54M |
|
|
|||||
| Total Accounts Payable | 683.00K | 850.00K | 470.00K | 496.00K | 158.00K |
| Total Accrued Expenses | 190.00K | 164.00K | 135.00K | 186.00K | 138.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 873.00K | 1.01M | 605.00K | 682.00K | 296.00K |
|
|
|||||
| Total Current Liabilities | 873.00K | 1.01M | 605.00K | 682.00K | 296.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 873.00K | 1.01M | 605.00K | 682.00K | 296.00K |
|
|
|||||
| Common Stock & APIC | 114.50M | 104.67M | 104.20M | 103.44M | 99.96M |
| Retained Earnings | -103.56M | -102.18M | -99.64M | -98.14M | -96.71M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 10.94M | 2.49M | 4.57M | 5.30M | 3.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.94M | 2.49M | 4.57M | 5.30M | 3.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.94M | 2.49M | 4.57M | 5.30M | 3.25M |
|
|
|||||